Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1967)
All Articles published online
|
Mar 14, 2007 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Xie Y, Zhou NJ, Gong YF, Zhou XJ, Chen J, Hu SJ, Lu NH, Hou XH. Th immune response induced by |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i10/1547.htm |
| Number | Citing Articles |
| 1 |
Kim S. Jones. Biomaterials as vaccine adjuvants. Biotechnology Progress 2008; 24(4): 807 doi: 10.1002/btpr.10
|
| 2 |
Dina Raafat, Hans‐Georg Sahl. Chitosan and its antimicrobial potential – a critical literature survey. Microbial Biotechnology 2009; 2(2): 186 doi: 10.1111/j.1751-7915.2008.00080.x
|
| 3 |
Kuang Yunle, Wu Tong, Liu Jiyang, Wu Guojun. Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants—A review. Helicobacter 2024; 29(1) doi: 10.1111/hel.13034
|
| 4 |
Le Guo, Runting Yin, Guangxian Xu, Xiaojuan Gong, Zisong Chang, Dantong Hong, Hongpeng Liu, Shuqin Ding, Xuebo Han, Yuan Li, Feng Tang, Kunmei Liu. Immunologic properties and therapeutic efficacy of a multivalent epitope‐based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils. Helicobacter 2017; 22(6) doi: 10.1111/hel.12428
|
| 5 |
Yingying Xing, Wei Liu, Xiaokang Li, Le Guo, Xiaobo Lv, Tao Xi. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori. Biochemical and Biophysical Research Communications 2015; 462(3): 269 doi: 10.1016/j.bbrc.2015.04.130
|
| 6 |
M.A. Barbosa, I.C. Gonçalves, P.M.D. Moreno, R.M. Gonçalves, S.G. Santos, A.P. Pêgo, I.F. Amaral. Comprehensive Biomaterials II. 2017; : 279 doi: 10.1016/B978-0-12-803581-8.10246-2
|
| 7 |
Karla S. Rocha Soares, Alice R. Oliveira, Alessandra Daniele-Silva, Fiamma Glaucia-Silva, Ana Luiza P. Caroni, Matheus F. Fernandes-Pedrosa, Arnóbio A. da Silva-Júnior. Self-assembled scorpion venom proteins cross-linked chitosan nanoparticles for use in the immunotherapy. Journal of Molecular Liquids 2017; 241: 540 doi: 10.1016/j.molliq.2017.06.071
|
| 8 |
Karla Soares, Fiamma Gláucia-Silva, Alessandra Daniele-Silva, Manoela Torres-Rêgo, Nathália Araújo, Yamara Menezes, Igor Damasceno, Denise Tambourgi, Arnóbio da Silva-Júnior, Matheus Fernandes-Pedrosa. Antivenom Production against Bothrops jararaca and Bothrops erythromelas Snake Venoms Using Cross-Linked Chitosan Nanoparticles as an Immunoadjuvant. Toxins 2018; 10(4): 158 doi: 10.3390/toxins10040158
|
| 9 |
Karla S. Rocha Soares, José L. Cardozo Fonseca, Mariana A. Oliveira Bitencourt, Kátia S.C.R. Santos, Arnóbio A. Silva-Júnior, Matheus F. Fernandes-Pedrosa. Serum production against Tityus serrulatus scorpion venom using cross-linked chitosan nanoparticles as immunoadjuvant. Toxicon 2012; 60(8): 1349 doi: 10.1016/j.toxicon.2012.09.010
|
| 10 |
M. Abdel‐Latif, G. El‐Shahawi, S. M. Aboelhadid, H. Abdel‐Tawab. Immunoprotective Effect of Chitosan Particles on Hymenolepis nana – Infected Mice. Scandinavian Journal of Immunology 2017; 86(2): 83 doi: 10.1111/sji.12568
|
| 11 |
Kanishtha Agarwal, Shvetank Agarwal. Helicobacter pylori Vaccine: From Past to Future. Mayo Clinic Proceedings 2008; 83(2): 169 doi: 10.4065/83.2.169
|
| 12 |
Reham S. Elezaby, Maha Nasr, Ibrahim M. El-Sherbiny. Chitosan in Biomedical Applications. 2022; : 245 doi: 10.1016/B978-0-12-821058-1.00002-2
|
| 13 |
F. Esmaeili, S. Heuking, H.E. Junginger, G. Borchard. Progress in chitosan-based vaccine delivery systems. Journal of Drug Delivery Science and Technology 2010; 20(1): 53 doi: 10.1016/S1773-2247(10)50006-6
|
| 14 |
Brendon Y. Chu, Mohammad Al Kobiasi, Weiguang Zeng, David Mainwaring, David C. Jackson. Chitosan-based particles as biocompatible delivery vehicles for peptide and protein-based vaccines. Procedia in Vaccinology 2012; 6: 74 doi: 10.1016/j.provac.2012.04.010
|
| 15 |
L. F. Sukhodub, L. B. Sukhodub, I. V. Chorna. Chitosan-apatite composites: synthesis and properties. Biopolymers and Cell 2016; 32(2): 83 doi: 10.7124/bc.000910
|
| 16 |
H. Çiğdem Arca, Merve Günbeyaz, Sevda Şenel. Chitosan-based systems for the delivery of vaccine antigens. Expert Review of Vaccines 2009; 8(7): 937 doi: 10.1586/erv.09.47
|
| 17 |
Rishikesh Gupta, Purnima Tripathi, Peeyush Bhardwaj, Alok Mahor. Recent advances in gastro retentive drug delivery systems and its application on treatment of H. Pylori infections. Journal of Analytical & Pharmaceutical Research 2018; 7(4) doi: 10.15406/japlr.2018.07.00258
|
| 18 |
Fushun Zhang, Chunsheng Hao, Shuo Zhang, Aqian Li, Quanfu Zhang, Wei Wu, Lin Liu, Chuan Li, Mifang Liang, Xiuling Li, Dexin Li. Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge. Virology Journal 2014; 11(1) doi: 10.1186/1743-422X-11-80
|
| 19 |
Inês C Gonçalves, Patrícia C Henriques, Catarina L Seabra, M Cristina L Martins. The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection. Expert Review of Anti-infective Therapy 2014; 12(8): 981 doi: 10.1586/14787210.2014.930663
|
| 20 |
Yuri M Vasiliev. Chitosan-based vaccine adjuvants: incomplete characterization complicates preclinical and clinical evaluation. Expert Review of Vaccines 2015; 14(1): 37 doi: 10.1586/14760584.2015.956729
|
| 21 |
Alexandra Bayrak, Pauline Prüger, Ulrich A. Stock, Martina Seifert. Absence of Immune Responses with Xenogeneic Collagen and Elastin. Tissue Engineering Part A 2013; 19(13-14): 1592 doi: 10.1089/ten.tea.2012.0394
|
| 22 |
Kanishtha Agarwal, Shvetank Agarwal. Helicobacter pylori Vaccine: From Past to Future. Mayo Clinic Proceedings 2008; 83(2): 169 doi: 10.1016/S0025-6196(11)60838-0
|
| 23 |
Inderjit Jabbal-Gill, Peter Watts, Alan Smith. Chitosan-based delivery systems for mucosal vaccines. Expert Opinion on Drug Delivery 2012; 9(9): 1051 doi: 10.1517/17425247.2012.697455
|
| 24 |
Yanfeng Gong, Liming Tao, Lei Jing, Dongsheng Liu, Sijun Hu, Wei Liu, Nanjin Zhou, Yong Xie, Yoshio Yamaoka. Association of TLR4 and Treg in Helicobacter pylori Colonization and Inflammation in Mice. PLOS ONE 2016; 11(2): e0149629 doi: 10.1371/journal.pone.0149629
|
| 25 |
Suresh Vyas, Rishi Paliwal, Shivani Paliwal. Chitin, Chitosan, Oligosaccharides and Their Derivatives. 2010; : 339 doi: 10.1201/EBK1439816035-c25
|
| 26 |
Iris Bosschem, Jagadeesh Bayry, Ellen De Bruyne, Kim Van Deun, Annemieke Smet, Griet Vercauteren, Richard Ducatelle, Freddy Haesebrouck, Bram Flahou, Luciana C. C. Leite. Effect of Different Adjuvants on Protection and Side-Effects Induced by Helicobacter suis Whole-Cell Lysate Vaccination. PLOS ONE 2015; 10(6): e0131364 doi: 10.1371/journal.pone.0131364
|
| 27 |
YANFENG GONG, LIMING TAO, FUCAI WANG, WEI LIU, LEI JING, DONGSHENG LIU, SIJUN HU, YONG XIE, NANJIN ZHOU. Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine. Molecular Medicine Reports 2015; 12(3): 4123 doi: 10.3892/mmr.2015.3950
|
| 28 |
Mi Lan Kang, Chong Su Cho, Han Sang Yoo. Application of chitosan microspheres for nasal delivery of vaccines. Biotechnology Advances 2009; 27(6): 857 doi: 10.1016/j.biotechadv.2009.06.007
|
| 29 |
Gerrit Borchard, Farnaz Esmaeili, Simon Heuking. Chitosan‐Based Systems for Biopharmaceuticals. 2012; : 211 doi: 10.1002/9781119962977.ch12
|
| 30 |
Nourhan H. AbdelAllah, Nourtan F. Abdeltawab, Abeer A. Boseila, Magdy A. Amin. Chitosan and Sodium Alginate Combinations Are Alternative, Efficient, and Safe Natural Adjuvant Systems for Hepatitis B Vaccine in Mouse Model. Evidence-Based Complementary and Alternative Medicine 2016; 2016: 1 doi: 10.1155/2016/7659684
|
| 31 |
Brendon Y. Chua, Mohammad Al Kobaisi, Weiguang Zeng, David Mainwaring, David C. Jackson. Chitosan Microparticles and Nanoparticles as Biocompatible Delivery Vehicles for Peptide and Protein-Based Immunocontraceptive Vaccines. Molecular Pharmaceutics 2012; 9(1): 81 doi: 10.1021/mp200264m
|
| 32 |
Zhiwei Sui, Quanjiao Chen, Rui Wu, Hongbo Zhang, Mei Zheng, Hanzhong Wang, Ze Chen. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant. Archives of Virology 2010; 155(4): 535 doi: 10.1007/s00705-010-0621-4
|
| 33 |
Zhiwei Sui, Quanjiao Chen, Fang Fang, Mei Zheng, Ze Chen. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant. Vaccine 2010; 28(48): 7690 doi: 10.1016/j.vaccine.2010.09.019
|
| 34 |
Jo‐Lewis Banga Ndzouboukou, Qing Lei, Nadeem Ullah, Yandi Zhang, Ling Hao, Xionglin Fan. Helicobacter pylori adhesins: HpaA a potential antigen in experimental vaccines for H. pylori. Helicobacter 2021; 26(1) doi: 10.1111/hel.12758
|
| 35 |
Fabienne Rauw, Yannick Gardin, Vilmos Palya, Sofia Anbari, Martine Gonze, Sophie Lemaire, Thierry van den Berg, Bénédicte Lambrecht. The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine. Veterinary Immunology and Immunopathology 2010; 134(3-4): 249 doi: 10.1016/j.vetimm.2009.10.028
|
| 36 |
Dongqing Luo, Jianhua Guo, Fengjie Wang, Jing Sun, Guangwu Li, Xiaoli Cheng, Mingquan Chang, Xuetao Yan. Preparation and Evaluation of Anti-Helicobacter pylori Efficacy of Chitosan Nanoparticles in Vitro and in Vivo. Journal of Biomaterials Science, Polymer Edition 2009; 20(11): 1587 doi: 10.1163/092050609X12464345137685
|
| 37 |
Anna T. Lampe, Eric J. Farris, Deborah M. Brown, Angela K. Pannier. High‐ and low‐molecular‐weight chitosan act as adjuvants during single‐dose influenza A virus protein vaccination through distinct mechanisms. Biotechnology and Bioengineering 2021; 118(3): 1224 doi: 10.1002/bit.27647
|